Type 2 diabetes mellitus (T2DM) makes up 90–95% of all diabetes and is characterized by chronic hyperglycemia due to impaired target tissue response to insulin (i.e., insulin resistance) and progressive deterioration of pancreatic β-cell function [1]. The gene discussed is INS; the disease is Insulin resistance.